We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant

4 hedge funds and large institutions have $337K invested in TriSalus Life Sciences Warrant in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.95% less ownership

Funds ownership: 2.95%0% (-3%)

20% less funds holding

Funds holding: 54 (-1)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

73% less capital invested

Capital invested by funds: $1.25M → $337K (-$912K)

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$199K +$188K +103,336 +439%
VI
2
Vestcor Inc
New Brunswick, Canada
$111K
ACM
3
Alpha Capital Management
Texas
$18.7K -$20.4K -11,222 -50%
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
$8.48K -$7.66K -4,213 -45%

TLSIW Hedge Fund Activity: Q3 2025 in Review

4 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2025, worth a combined $337K — down 73% from $1.25M a quarter earlier.

Fund positioning in TLSIW was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $188K. The largest seller was Alpha Capital Management, cutting an estimated $20.4K.

  • 4 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2025, down from 5 in Q2 2025.
  • Funds reported $337K of TriSalus Life Sciences Warrant stock for Q3 2025, down 73% quarter-over-quarter.
  • 0 funds opened new TriSalus Life Sciences Warrant positions in Q3 2025 and 0 closed out.
  • The largest TriSalus Life Sciences Warrant buyer in Q3 2025 was Citadel Advisors, an estimated $188K added.
  • The largest TriSalus Life Sciences Warrant seller in Q3 2025 was Alpha Capital Management, an estimated $20.4K sold.

Based on aggregated 13F filings for Q3 2025.